| Literature DB >> 25356409 |
Alex A MacDonald1, Ken N Seergobin1, Ruzbeh Tamjeedi2, Adrian M Owen3, Jean-Sebastien Provost4, Oury Monchi4, Hooman Ganjavi5, Penny A MacDonald6.
Abstract
OBJECTIVE: Understanding cognition mediated by the striatum can clarify cognitive deficits in Parkinson's disease (PD). Previously, we claimed that dorsal striatum (DS) mediates cognitive flexibility. To refute the possibility that variation in cognitive effort confounded our observations, we reexamined our data to dissociate cognitive flexibility from effort. PD provides a model for exploring DS-mediated functions. In PD, dopamine-producing cells supplying DS are significantly degenerated. DS-mediated functions are impaired off and improved on dopamine replacement medication. Functional magnetic resonance imaging (fMRI) can confirm striatum-mediated functions.Entities:
Year: 2014 PMID: 25356409 PMCID: PMC4184667 DOI: 10.1002/acn3.62
Source DB: PubMed Journal: Ann Clin Transl Neurol ISSN: 2328-9503 Impact factor: 4.511
Experiment 1: demographics and clinical information, as well as screening cognitive and affective measures for PD patients and controls
| Group | Age | Education | Years disease | DA ( | UPDRS ON | UPDRS OFF | ||
|---|---|---|---|---|---|---|---|---|
| PD | 22 | 63.18 (2.00) | 13.82 (0.87) | 5.16 (1.27) | 480 (65.31) | 6 | 17.22 (1.60) | 22.36 (1.89) |
| CT | 22 | 62.27 (1.63) | 12.86 (0.65) | – | – | – | – | – |
Values are presented as group means (SEM). Screening cognitive and affective measures were completed by patients on medication unless indicated otherwise. Control participants did NOT receive dopaminergic therapy during any session of the experiment. Their data are presented here to correspond to the OFF-ON order of the PD patient to whom they were matched. Education, years of education; Years disease, years since diagnosis of PD; l-DOPA, daily l-DOPA equivalent dose in mg; DA, number of patients taking dopamine agonists; UPDRS ON, Unified Parkinson's Disease Rating Scale motor score on medication; UPDRS OFF, Unified Parkinson's Disease Rating Scale motor score off medication; ANART IQ, National Adult Reading Test (Nelson and Willison, 1991) IQ estimation; BDI-II ON, Beck Depression Inventory II score measured for PD patients while they were treated with their usual dopamine replacement therapy and for control participants during the session that corresponded to the ON session of the PD patient to whom they were matched; BDI-II OFF, Beck Depression Inventory II score measured for PD patients while they abstained from their usual dopamine replacement therapy and for control participants during the session that corresponded to the OFF session of the PD patient to whom they were matched; Apathy, Apathy Evaluation Scale score; F-words, number of words beginning with the letter F generated in 1 min; Clock, score on clock drawing component of Montreal Cognitive Assessment (MOCA); Cube, score on cube copying component of MOCA.
Figure 1Three consecutive trials, each consisting of a prime and probe event, for symbolic distances of 1 (top), 2 (middle), and 3 (bottom) between number pairs on the prime event are presented. Four “plus” signs were presented to orient the participant's attention to the center of the computer screen, prior to each event. A large box with thick lines signaled that the larger number in the pair was the target. A small box with thin lines indicated that the smaller number in the pair was the target. Participants were instructed to read aloud the target number, for each event, as quickly yet as accurately as possible. For illustrative purposes in the figure only, the target is presented in bold, whereas the distracter appears in regular font. Notice that the selection criterion (i.e., larger or smaller number) did not change from the probe event on one trial and the prime event on the subsequent trial. Furthermore, note that there was no systematic relation between the numbers presented on the probe event on one trial and the numbers appearing in the subsequent prime event. Below the example trials, we present a timeline showing the sequence and durations of events for a single trial. Each trial began with a fixation stimulus (i.e. four plus signs) for 500 msec, followed by a blank screen for 500 msec. A pair of numbers was presented one above the other, within a large or a small box, constituting the prime event. The stimuli remained on the screen until the participant gave a response into a microphone, ending the timer. A blank screen was presented for 500 msec during which the experimenter scored the participant's response. A fixation stimulus and a blank screen were presented again, each for 500 msec, prior to the probe event, which consisted of two numbers one above the other within a large or a small box. The probe display ended when the participant gave a response into a microphone. A blank screen occurred during which the experimenter scored performance on the probe event.
Figure 2(A) Experiment 1: mean response times for selections on prime events as a function of the symbolic distance (1, 2, or 3) between number pairs, for PD patients and healthy controls in both experimental sessions. The blue line designates performance of PD patients on medication whereas the red line presents their performance off dopaminergic medication. Although control participants did not receive dopaminergic therapy during either experimental session, their data are presented to correspond to the OFF (mauve line) versus ON (green line) session of the PD patient to whom they were matched. Error bars represent SEM. (B) Experiment 1: mean error rates (SEM) for selections on prime events as a function of the symbolic distance (1, 2, or 3) between number pairs, for PD patients and healthy controls in both experimental sessions.
Experiment 2: mean response times (SEM) and error rates (SEM) for selections on prime events as a function of the symbolic distance (1, 2, or 3) between number pairs
| RTs | Errors | |
|---|---|---|
| Distance 1 | 1130 (50.39) | 0.054 (0.010) |
| Distance 2 | 1088 (52.46) | 0.046 (0.009) |
| Distance 3 | 1100 (54.31) | 0.032 (0.008) |
Experiment 2: brain regions in which BOLD response significantly correlated with symbolic distance
| Anatomical area | Cluster size | ||||
|---|---|---|---|---|---|
| L occipital region | −42 | −88 | −6 | 6.01 | 26,176 |
| L fusiform area | −44 | −70 | −16 | 5.78 | 26,176 |
| L cerebellum | −54 | −60 | −32 | 4.58 | 26,176 |
| L cerebellum | −18 | −66 | −18 | 4.02 | 26,176 |
| R occipital region | 18 | −42 | −82 | 6.03 | 20,144 |
| R inferior temporal gyrus | 40 | −68 | −20 | 5.34 | 20,144 |
| R cerebellum | 28 | −62 | −36 | 4.55 | 20,144 |
| R fusiform area | 54 | −56 | −14 | 4.55 | 20,144 |
| R cerebellum | 34 | −46 | −28 | 4.33 | 20,144 |
| L supplementary motor area | −6 | 12 | 58 | 5.40 | 17,984 |
| R cingulate cortex | 10 | 20 | 46 | 4.47 | 17,984 |
| R supplementary motor area | 4 | 20 | 58 | 4.26 | 17,984 |
| L dorsomedial frontal cortex | −2 | 52 | 44 | 4.15 | 17,984 |
| L premotor cortical areas | −40 | 4 | 58 | 5.25 | 7392 |
| −26 | −4 | 58 | 4.25 | 7392 | |
| −64 | 0 | 32 | 4.44 | 7392 | |
| Vermis | 2 | −82 | −36 | 5.3 | 2032 |
| R medial orbitofrontal cortex | 20 | 50 | −10 | 4.48 | 1864 |
| R posterior parietal cortex | 34 | −84 | 24 | 4.57 | 608 |